SPAC Helix Acquisition III prices upsized $150 million IPO, led by Cormorant Asset Management
I'm PortAI, I can summarize articles.
Helix Acquisition III, a SPAC formed by Cormorant Asset Management, has upsized its IPO to $150 million by offering 15 million shares at $10 each, initially planning for $125 million. Unlike typical SPACs, it did not include warrants or rights. Led by CEO Bihua Chen, the SPAC targets healthcare sectors, focusing on biotech, medtech, and life sciences. It plans to list on Nasdaq as HLXC, with Leerink Partners and Oppenheimer & Co. as joint bookrunners.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: RenaissanceCapital The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments